Active Clinical Research: Pancreatic Cancer

Comprehensive Cancer Centers is currently running the following Phase II and Phase III clinical research studies for pancreatic cancer:

Pivotal, randomized, open-label study of Tumor Treating Fields (TTFields, 150kHz) concomitant with gemcitabine and nab-paclitaxel for front-line treatment of locally-advanced pancreatic adenocarcinoma
Study#: i2540 Phase III
Contact Us: For information about this clinical study, Email Us, or use our form field.

An Open-Label, Randomised, Multicentre, Phase III Study Of Irinotecan Liposome Injection, Oxaliplatin, 5-Fluorouracil/Leucovorin Versus Nab-Paclitaxel Plus Gemcitabine In Subjects Who Have Not Previously Received Chemotherapy For Metastatic Adenocarcinoma Of The Pancreas
Study#: i2749 Phase III
Contact Us: For information about this clinical study, Email Us, or use our form field.